Finance

Lists
500087:BOM
Cipla Ltd
₹ 1,346.85
-0.23%
(-3.15) 1D
10-р сарын 1, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500087...
Open
₹ 1,346.05
High
₹ 1,359.00
Low
₹ 1,334.00
Mkt. cap
1.09ИН
Avg. vol.
40.32 мян
Volume
47.14 мян
Dividend
0.97%
Quarterly dividend
₹ 3.25
Ex-dividend date
2026 оны 6-р сарын 5
P/E ratio
32.30
52-wk high
₹ 1,672.20
52-wk low
₹ 1,165.55
EPS
₹ 41.70
Shares outstanding
805.67 сая
No. of employees
31 мян
Open
₹ 1,346.05
High
₹ 1,359.00
Low
₹ 1,334.00
Mkt. cap
1.09ИН
Avg. vol.
40.32 мян
Volume
47.14 мян
Dividend
0.97%
Quarterly dividend
₹ 3.25
Ex-dividend date
2026 оны 6-р сарын 5
P/E ratio
32.30
52-wk high
₹ 1,672.20
52-wk low
₹ 1,165.55
EPS
₹ 41.70
Shares outstanding
805.67 сая
No. of employees
31 мян
News stories
From web sources and news partners
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31.4 мян
Founded1935
HeadquartersМумбай, Махараштра, Энэтхэг
SectorPharmaceutical industry
Websitecipla.com
Last report
2026 оны 7-р сарын 23
Fiscal period
Q1 2027
EPS / Est. (INR)
₹ 9.76 / ₹ 10.42
-6.36%miss
Revenue / Est. (INR)
70.77 тэрбум / 71.42 тэрбум
-0.91%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
74.47 тэрбум
69.63 тэрбум
65.80 тэрбум
70.77 тэрбум
Cost of goods sold
24.98 тэрбум
26.32 тэрбум
25.10 тэрбум
26.67 тэрбум
Cost of revenue
24.98 тэрбум
26.32 тэрбум
25.10 тэрбум
26.67 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.15 тэрбум
13.25 тэрбум
28.23 тэрбум
14.97 тэрбум
Operating expense
33.52 тэрбум
33.54 тэрбум
33.30 тэрбум
35.22 тэрбум
Total operating expenses
58.50 тэрбум
59.86 тэрбум
58.39 тэрбум
61.89 тэрбум
Operating income
15.98 тэрбум
9.77 тэрбум
7.41 тэрбум
8.88 тэрбум
Other non operating income
2.69 тэрбум
2.06 тэрбум
-5.35 тэрбум
2.11 тэрбум
EBT including unusual items
18.54 тэрбум
8.93 тэрбум
6.99 тэрбум
10.80 тэрбум
EBT excluding unusual items
18.54 тэрбум
11.69 тэрбум
4.51 тэрбум
10.80 тэрбум
Income tax expense
5.00 тэрбум
2.19 тэрбум
1.57 тэрбум
2.95 тэрбум
Effective tax rate
27.00%
24.48%
22.44%
27.29%
Other operating expenses
17.40 тэрбум
17.51 тэрбум
2.51 тэрбум
17.20 тэрбум
Net income
13.51 тэрбум
6.76 тэрбум
5.55 тэрбум
7.89 тэрбум
Net profit margin
18.14%
9.71%
8.43%
11.15%
Earnings per share
16.72
10.94
6.86
9.76
Interest and investment income
-
-
2.07 тэрбум
-
Interest expense
-131.80 сая
-140.30 сая
-69.70 сая
-170.30 сая
Net interest expenses
-131.80 сая
-140.30 сая
2.00 тэрбум
-170.30 сая
Depreciation and amortization charges
2.97 тэрбум
2.78 тэрбум
2.56 тэрбум
3.04 тэрбум
EBITDA
18.73 тэрбум
12.00 тэрбум
9.82 тэрбум
11.29 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс